Loading clinical trials...

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs) | Clinical Trials | Clareo Health

COMPLETED

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

Characterizing the Recovery Phase of Acute Exacerbations of COPD Using Wearable Remote Monitoring Technology

NCT05776654•McGill University Health Centre/Research Institute of the McGill University Health Centre

Summary

The purpose the study is to successfully characterize the recovery phase of acute exacerbations of COPD in the outpatient setting using remotely captured physiologic data from wearable devices, to compare this with patient self-reported symptom data, to determine which physiologic variable(s) best correspond with AECOPD recovery, and to further document the feasibility, data quantity, data quality, and COPD outpatient usability experience with wearable devices.

Eligibility

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Males/females, age ≥40, former/current smokers with ≥10 pack-year smoking history
•2. Currently experiencing/receiving treatment for a physician-diagnosed AECOPD
•3. Forced expired volume in the first second (FEV1) / Forced vital capacity (FVC) \< 0.7 (GOLD 1-4)
•4. Ability to provide informed consent

Exclusion Criteria

•1. No existing COPD diagnosis
•2. History of cardiac arrhythmia
•3. Presence of pacemaker/defibrillator
•4. Any medical/cognitive/functional condition which renders inability to don/doff/recharge devices and complete symptom questionnaire
•5. Have already received 4 or more days of consecutive corticosteroid and/or antibiotic therapy since presenting to medical attention for their AECOPD

Locations (1)

McGill University Health Centre

Montreal, Quebec, Canada

Key Dates

Start Date

February 16, 2023

Primary Completion Date

January 15, 2024

Completion Date

January 15, 2024

Last Updated

May 29, 2024

Enrollment

ACTUAL participants

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease Exacerbation

Interventions

Biometric wearable devices

DEVICE

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGPHASE3

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769

Chronic Obstructive Pulmonary Disease

View study

RECRUITINGNA

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 29, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Probiotics in Pulmonaty Rehabilitation for COPD

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease